Core Viewpoint - The article highlights the efforts of the Yuhang District Market Supervision Administration to enhance drug safety regulation in small pharmacies, clinics, and beauty shops, focusing on protecting public health through targeted governance measures [1][2]. Group 1: Regulatory Measures - The Yuhang District Market Supervision Administration has initiated a special governance campaign targeting "three smalls" (small pharmacies, small clinics, small beauty shops) to address drug safety concerns [1]. - A dynamic electronic file system has been established for 1,155 "three smalls" units, including 313 small pharmacies, 182 small clinics, and 660 small beauty shops, integrating various regulatory data for precise monitoring [2]. - The administration has identified 79 key regulatory targets, increasing the frequency and rigor of inspections for these entities [2]. Group 2: Compliance and Rectification - A closed-loop mechanism has been created, consisting of a subject information list, problem list, and rectification list, ensuring that all issues are tracked and resolved online [4]. - The administration has conducted eight inspection campaigns, resulting in legal penalties for 30 entities, including 14 beauty shops, 9 clinics, and 7 pharmacies, to enforce accountability [4]. - A total of 132 identified issues have been fully rectified, demonstrating the commitment to drug safety [4]. Group 3: Support for Operators - The Yuhang District has organized training and collective discussions for over 400 operators of "three smalls," clarifying key regulations such as the Drug Administration Law and negative lists [4]. - The administration has implemented measures to strengthen social supervision, including signing responsibility agreements and providing public reporting channels [4]. - The approach combines digital governance with human-centered guidance to foster trust in drug safety [4].

7月30日，国家药监局官网发布了关于开展2025年"全国药品安全宣传周"活动的通知。2025年"宣传 周"活动时间为9月1日至7日，主题为"药品安全监管为民"。 2025年是"十四五"规划收官之年，也是全面深化药品监管改革再出发的一年。今年的"宣传周"将重点围 绕国家药监局成立以来，尤其是"十四五"期间药品监管工作取得的成效，集中展现药品监管部门全力保 障高水平安全，促进医药产业高质量发展，进一步深化药品监管改革，落实《国务院办公厅关于全面深 化药品医疗器械监管改革促进医药产业高质量发展的意见》等相关政策要求的工作举措，增强公众对药 品监管工作的信任与支持。深入开展"两品一械"科普宣传教育，通过多种形式宣传"两品一械"安全相关 科普知识，进一步提高公众科学素养，营造全社会共治共享良好氛围。(经济日报记者佘惠敏) ...

Group 1 - Hainan has become the first province in China to establish regulatory documents for the circulation management of antibacterial drugs, creating a comprehensive management system for the entire process of production, operation, and use of these drugs [1] - The newly introduced regulations detail requirements for sales management, quality management, prescription review, medication guidance, and product traceability, emphasizing the responsibility of enterprises and personnel for drug safety [1] - The regulations aim to prevent the misuse of antibacterial drugs, which can lead to drug abuse and bacterial resistance, by focusing on retail channels and prescription reviews to prevent illegal distribution [1] Group 2 - Hainan has conducted multiple safety actions over the past three years to strengthen drug retail supervision, addressing issues such as illegal drug purchases, improper sales of prescription drugs, and unlicensed pharmacists [2] - The "Clean Source" action this year has inspected 3,342 retail pharmacies, ordered 311 companies to rectify issues, and initiated 99 legal cases, with three cases referred to law enforcement, ensuring stability in the drug circulation market [2] - The province has implemented a drug traceability platform to enhance the transparency of drug sources and destinations in retail pharmacies [2]

Group 1 - The core focus of the news is the "Qingyuan" action initiated by the Tai'an Market Supervision Administration to enhance drug safety and address public concerns regarding drug management [1][2] - The action has been integrated into the annual drug regulation key task list, with a detailed work plan established in collaboration with the municipal administrative approval service bureau [1] - A specialized task force has been formed, consisting of three functional groups: comprehensive, supervision inspection, and case handling, to ensure effective implementation of the action [1] Group 2 - The "Qingyuan" action targets illegal online drug sales, expired and counterfeit drugs, and the unauthorized sale of prescription drugs, focusing on key units and products [2] - Comprehensive inspections are being conducted using on-site checks and online monitoring to effectively combat illegal activities and create a deterrent effect [2] - The Tai'an Market Supervision Administration plans to deepen the "Qingyuan" action by increasing risk assessment efforts and investigating illegal leads to ensure public safety in drug use [2]